HAIGHT NELSON M
Transaction: 03/18/2026
OTHER
Change
+10,000
Price
$0.88
Filing
03/31/2026
Type
OTHER
Virax Biolabs Group Limited
VRAX • Biotechnology
$2.63
▲ +0.06 (+2.54%)
Current price
EarningsLatest report: Sep 30, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$12.50M
Growth
-52.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.07Healthy liquidity · 7.27Negative growth trendWeak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Sep 30, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.63
Change2.54%
Shares Out4.76M
Market Cap$12.50M
Enterprise Value$9.35M
52W Range2.50 - 28.50
Beta1.33
P/E-1.02
P/S142.31
P/B2.35
P/FCF-1.11
EV/Sales106.46
Price$2.63
Change2.54%
Shares Out4.76M
Market Cap$12.50M
Enterprise Value$9.35M
52W Range2.50 - 28.50
Beta1.33
P/E-1.02
P/S142.31
P/B2.35
P/FCF-1.11
EV/Sales106.46
EV/EBITDA-0.78
EV/FCF-0.83
Earnings Yield-97.77%
FCF Yield-90.31%
Dividend Yield0.00%
Gross Margin-8.38%
Oper. Margin-973.45%
Profit Margin-957.39%
Debt/Eq0.07
Current Ratio7.27
Quick Ratio7.13
Revenue 5Y-52.86%
Target$1.00
Target Upside-61.90%
Target Median$1.00
Target Range1.00 - 1.00
Volume114.34K
Avg Volume1.15M
Investment DNA
How strong this company looks for long-term investors
38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Manageable debt level · 0.07Healthy liquidity · 7.27Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-07-08
Low
$1.00
Mean
$1.00
Median
$1.00
High
$1.00
Insider Transactions
Recent executive and insider activity
McCracken Nigel William
Transaction: 03/18/2026
OTHER
Change
+29,416
Price
$0.88
Filing
03/20/2026
Type
OTHER
Miller Iain David
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/18/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| HAIGHT NELSON M | OTHER | +10,000 | $0.88 | 03/18/2026 | 03/31/2026 |
| McCracken Nigel William | OTHER | +29,416 | $0.88 | 03/18/2026 | 03/20/2026 |
| Miller Iain David | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Davis Jason | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Norton Evan Michael | OTHER | +10,000 | $0.88 | 03/18/2026 | 03/18/2026 |
| Foster James Alexander Cunliffe | OTHER | +31,975 | $0.88 | 03/18/2026 | 03/18/2026 |
| Foster James Alexander Cunliffe | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |